Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myxoma virus jumps species to the Iberian hare.
Dalton KP, Martín JM, Nicieza I, Podadera A, de Llano D, Casais R, Gimenez S, Badiola I, Agüero M, Duran M, Buitrago D, Romero LJ, García E, Parra F. Dalton KP, et al. Among authors: garcia e. Transbound Emerg Dis. 2019 Nov;66(6):2218-2226. doi: 10.1111/tbed.13296. Epub 2019 Aug 4. Transbound Emerg Dis. 2019. PMID: 31322320
Monitoring of emerging myxoma virus epidemics in Iberian hares (Lepus granatensis) in Spain, 2018-2020.
García-Bocanegra I, Camacho-Sillero L, Caballero-Gómez J, Agüero M, Gómez-Guillamón F, Manuel Ruiz-Casas J, Manuel Díaz-Cao J, García E, José Ruano M, de la Haza R. García-Bocanegra I, et al. Among authors: garcia e. Transbound Emerg Dis. 2021 May;68(3):1275-1282. doi: 10.1111/tbed.13781. Epub 2020 Aug 20. Transbound Emerg Dis. 2021. PMID: 32786107
Concomitance and interactions of pathogens in the Iberian wolf (Canis lupus).
Oleaga A, Vicente J, Ferroglio E, Pegoraro de Macedo MR, Casais R, del Cerro A, Espí A, García EJ, Gortázar C. Oleaga A, et al. Among authors: garcia ej. Res Vet Sci. 2015 Aug;101:22-7. doi: 10.1016/j.rvsc.2015.05.010. Epub 2015 May 24. Res Vet Sci. 2015. PMID: 26267084
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
Prevalence and Magnitude of Olfactory Dysfunction in Allergic Rhinitis.
Fornazieri MA, Garcia ECD, Montero RH, Borges R, Bezerra TFP, Pinna FR, Doty RL, Voegels RL. Fornazieri MA, et al. Among authors: garcia ecd. Am J Rhinol Allergy. 2024 May 17:19458924241253642. doi: 10.1177/19458924241253642. Online ahead of print. Am J Rhinol Allergy. 2024. PMID: 38759958
3,839 results